@article{2afeed5b5ce84b72bc84fed6c46dc07b,
title = "MOB1 regulates thymocyte egress and T-cell survival in mice in a YAP1-independent manner",
abstract = "Mammalian STE20-like protein kinase 1/2 (MST1/2) and nuclear Dbf2-related kinase 1/2 (NDR1/2) are core components of Hippo signaling that are also known to be important regulators of lymphocyte trafficking. However, little is understood about the roles of other Hippo pathway molecules in these cells. Here, we present the first analysis of the function of Mps one binder kinase activator-1 (MOB1) in T lymphocytes in vivo. T-cell-specific double knockout (DKO) of MOB1A/B in mice [tMob1 DKO mice] reduces the number of na{\"i}ve T cells in both the circulation and secondary lymphoid organs, but leads to an accumulation of CD4+CD8− and CD4−CD8+ single-positive (SP) cells in the thymus. In vitro, na{\"i}ve MOB1A/B-deficient T cells show increased apoptosis and display impaired trafficking capacity in response to the chemokine CCL19. These defects are linked to suppression of the activation of MST and NDR kinases, but are independent of the downstream transcriptional co-activator Yes-associated protein 1 (YAP1). Thus, MOB1 proteins play an important role in thymic egress and T-cell survival that is mediated by a pathway other than conventional Hippo-YAP1 signaling.",
author = "Wakako Kato and Miki Nishio and Yoko To and Hideru Togashi and Mak, {Tak Wah} and Hidetoshi Takada and Shouichi Ohga and Tomohiko Maehama and Akira Suzuki",
note = "Funding Information: Japanese Society for the Promotion of Science, Grant/Award Number: 17H01400 and 26114005; Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University; Nanken‐Kyoten, Tokyo Medical and Dental University (TMDU); Project for Development of Innovative Research on Cancer Therapeutics, Grant/Award Number: 11088019; Japanese Agency for Medical Research and Development, Grant/Award Number: JP19cm0106114 Funding Information: We thank Y. Shimono and K. Okada (Kobe University) for expert technical assistance and critical discussions. We are grateful for the funding provided by the Japanese Society for the Promotion of Science (JSPS; grants 17H01400 and 26114005 to A.S.); the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University; Nanken‐Kyoten, Tokyo Medical and Dental University (TMDU); the Project for Development of Innovative Research on Cancer Therapeutics (P‐DIRECT; grant 11088019 to A.S.); and the Japanese Agency for Medical Research and Development (AMED; grant JP19cm0106114 to A.S.). Publisher Copyright: {\textcopyright} 2019 Molecular Biology Society of Japan and John Wiley & Sons Australia, Ltd",
year = "2019",
month = jul,
doi = "10.1111/gtc.12704",
language = "English",
volume = "24",
pages = "485--495",
journal = "Genes to Cells",
issn = "1356-9597",
publisher = "Wiley-Blackwell",
number = "7",
}